Choi Hanlim, Kwon Soon Kil, Han Joung-Ho, Lee Jun Su, Kang Gilwon, Kang Minseok
Department of Surgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
Kidney Res Clin Pract. 2022 Mar;41(2):253-262. doi: 10.23876/j.krcp.20.250. Epub 2021 Dec 13.
Patients on dialysis have numerous gastrointestinal problems related to uremia, which may represent concealed cholecystitis. We investigated the incidence and risk of acute cholecystitis in dialysis patients and used national health insurance data to identify acute cholecystitis in Korea.
The Korean National Health Insurance Database was used, with excerpted data from the insurance claim of the International Classification of Diseases code of dialysis and acute cholecystitis treated with cholecystectomy. We included all patients who commenced dialysis between 2004 and 2013 and selected the same number of controls via propensity score matching.
A total of 59,999 dialysis and control patients were analyzed; of these, 3,940 dialysis patients (6.6%) and 647 controls (1.1%) developed acute cholecystitis. The overall incidence of acute cholecystitis was 8.04-fold higher in dialysis patients than in controls (95% confidence interval, 7.40-8.76). The acute cholecystitis incidence rate (incidence rate ratio, 23.13) was especially high in the oldest group of dialysis patients (aged ≥80 years) compared with that of controls. Dialysis was a significant risk factor for acute cholecystitis (adjusted hazard ratio, 8.94; 95% confidence interval, 8.19-9.76). Acute cholecystitis developed in 3,558 of 54,103 hemodialysis patients (6.6%) and in 382 of 5,896 patients (6.5%) undergoing peritoneal dialysis.
Patients undergoing dialysis had a higher incidence and risk of acute cholecystitis than the general population. The possibility of a gallbladder disorder developing in patients with gastrointestinal problems should be considered in the dialysis clinic.
透析患者存在许多与尿毒症相关的胃肠道问题,这些问题可能提示隐匿性胆囊炎。我们调查了透析患者急性胆囊炎的发病率和风险,并利用国家健康保险数据识别韩国的急性胆囊炎病例。
使用韩国国家健康保险数据库,摘录其中有关透析国际疾病分类代码及接受胆囊切除术治疗的急性胆囊炎的保险理赔数据。我们纳入了2004年至2013年间开始透析的所有患者,并通过倾向评分匹配选择了相同数量的对照。
共分析了59,999例透析患者和对照;其中,3,940例透析患者(6.6%)和647例对照(1.1%)发生了急性胆囊炎。透析患者急性胆囊炎的总体发病率比对照高8.04倍(95%置信区间,7.40 - 8.76)。与对照相比,年龄最大的透析患者组(≥80岁)的急性胆囊炎发病率(发病率比,23.13)尤其高。透析是急性胆囊炎的一个显著危险因素(调整后风险比,8.94;95%置信区间,8.19 - 9.76)。54,103例血液透析患者中有3,558例(6.6%)发生急性胆囊炎,5,896例腹膜透析患者中有382例(6.5%)发生急性胆囊炎。
透析患者急性胆囊炎的发病率和风险高于普通人群。在透析诊所应考虑胃肠道问题患者发生胆囊疾病的可能性。